THPO (thrombopoietin) is an essential cytokine that serves as the primary regulator of platelet production and hematopoietic stem cell (HSC) maintenance 1. The protein functions by binding to its receptor MPL, forming a homodimeric signaling complex that activates multiple downstream pathways including JAK/STAT and ERK/AKT/CREB signaling 1. THPO acts at late stages of megakaryocyte development, promoting both megakaryocyte differentiation and platelet production while simultaneously maintaining HSC pools 1. The gene's transcription is regulated by transcription factors ETS1 and STAT4 binding to its promoter region 2. Disease-associated mutations in THPO cause congenital amegakaryocytic thrombocytopenia type 2 (CAMT2), characterized by severe thrombocytopenia progressing to bone marrow failure 32. Pathogenic variants can affect coding regions, splicing sites, or regulatory sequences, commonly resulting in increased THPO protein production through mechanisms like upstream open reading frame disruption 4. Clinically, THPO deficiency can be treated with THPO receptor agonists, demonstrating the therapeutic importance of understanding this pathway in bone marrow failure disorders 25.